Ukudla kokungabi nhlobo kokudla kanye nokuphuza ngokweqile kuhlaselwa ukwelashwa kwe-eczema
I-aperic dermatitis ivame ukuqala isifo sokugula, esithinta izingane ezincane, ngokuvamile ngaphambi kweminyaka emihlanu ubudala. I-apiic dermatitis ibangelwa yizifo ezikudla nokudla okunemvelo (njenge-pollen, isikhunta, i-pet dander kanye nezidakamizwa zothuli) ezingamaphesenti angu-85 abantu abathintekayo. Ezinganeni eziningi ezine-atopic dermatitis, i- rhinitis ye-allergen izoqala ukukhula esikoleni esikoleni, kanti ezinye zalezi zingane zizokhula nge- asthma ngokukhula.
Lokhu kuqhubeka kwesifo sofuba kubizwa ngokuthi "ukuhamba kwe-atopic" . Kuye kwaba nempumelelo ekuvimbeleni ukuhamba kwezimoto ngokusebenzisa imithi kanye nokuzivikela komzimba (ukudosa umzimba) .
Kunezifo ezihlukahlukene ezitholakala kulezi zifo ezihlukahlukene zokugula, kuhlanganise nokugwema izifo ezithathelwanayo, imithi, kanye nokusetshenziswa kwe-immunotherapy. I-Immunotherapy, kuhlanganise nokudonswa kwamagciwane kanye nezinsizakalo zomzimba, yizo kuphela zokwelapha ezibangelwa yizokwelapha kuphela ezishintsha inkinga engaphansi kwezokwelapha, futhi yiyona kuphela yokwelashwa okungenzeka. Sekuyiminyaka eminingi, i-immunotherapy isetshenziselwe ukwelashwa kwe-rhinitis ye-allergen, i-allergenctivitis ye-allergen, ne-asthma ye-allergen. Muva nje, ukuhlola okuhlukahlukene kuphakamisa ukuthi imithi yokugoma i-immunotherapy ingase ibe usizo ekwelapheni i-atopic dermatitis.
Ukwelashwa kokungezwani komzimba kwe-Atopic Dermatitis
Ucwaningo oluningi luye lwaqhutshwa eminyakeni yamuva ukuthi luhlolisise ukuthi kungenzeka ukuthi ukubhebhetheka komzimba kungasiza ekunakekeleni i-atopic dermatitis.
Eziningi zalezi zifundo ziveze ukuthi ukukhwabanisa komzimba kungasiza ekunciphiseni izimpawu ze-atopic dermatitis (njengoba kulinganiswa yi-SCORAD - ithuluzi eliwusizo ekunikezeni inani lamanani ngokusezingeni lesikhumba elihilelekile, kusuka ku-1 kuya ku-100) kanye nokunciphisa ama-steroids angama-topical okudingekayo ukulawula izimpawu. Ukukhishwa kwesifo sofuzo kwakuphumelela kakhulu ekwelapheni abantu abane-atopic dermatitis eyingozi kakhulu, namanani we-SCORAD angaphezu kuka-40, kanye nabantu abanezintuthwane ezithwala uthuli njenge-trigger ye-dermatitis yabo ye-atopic.
I-allergies Drops for Atopic Dermatitis
Ukwehla kwesifo sofuzo, noma ukuxilongwa kwe-immunotherapy, kufaka hlangana ukuthatha lokho umuntu ayenakho ukuhlunga khona futhi ukubeka ngaphansi kolimi. Umphumela ufana kakhulu nezidakamizwa zendabuko yokunciphisa umzimba - ukunciphisa izibonakaliso zokungezwani komzimba, ukunciphisa inani lemithi yokwelashwa okudingekayo, futhi kungenzeka ukuthi imithi yokwelashwa iyakwelashwa. Ukwehla kwesifo sofuzo, ngenkathi sisetshenziswa eYurophu amashumi eminyaka, kubhekwe njengophenyo e-United States njengamanje, ngakho-ke kuhlinzekwa kuphela yi-allergists embalwa. Njengoba kufana nokudonswa kwamandla omzimba, ukwehla kwamagciwane kuye kwasetshenziselwa ukwelashwa kwe-rhinitis ye-allergic, i-conjunctivitis ye-allergen, ne-asthma ye-allergen - kodwa ngokuvamile ayisetshenziselwa i-atopic dermatitis.
Ucwaningo oluthile luye lwahlola inzuzo yokunciphisa ukungezwani komzimba ukuze ukwelashwa kwe-atopic dermatitis, bonke abantu abanomdlandla wokungcola. Ucwaningo olwanyatheliswa ngo-2007 lwathola ukuthi ukungezwani komzimba okuqukethe utshwala kwakuphumelela ekwelapheni kwe-dermatitis ye-atopic dermatitis (nge-SCORAD phakathi kuka-8 no-40). Kuleli qembu, kwaba khona ukwehla kwezimpawu ze-atopic dermatitis nokunciphisa inani lemithi edingekayo yokwelapha izimpawu ze-atopic dermatitis. Ukunciphisa izidakamizwa akuzange kusize ekunakekeleni i-atopic dermatitis enamandla (SCORAD engaphezu kuka-40) ebangelwa ukungcola komzimba.
Ukuphepha kwe-Immunotherapy ye-Atopic Dermatitis
Izifo zokudla kokungezwani komzimba ngokuvamile ziwukwelapha okuphephile futhi okuphumelelayo kwezimo ezihlukahlukene zokugula; ngenxa yokuthi kungenzeka ukuba i- anaphylaxis , noma kunjalo, abantu abathola imithi yokuzivikela kufanele bahlolwe ehhovisi likadokotela imizuzu engu-30. Ngakolunye uhlangothi, izifo ezibangelwa umfutho wegazi ziyekezwa ekhaya, zinikezwa ingozi ephansi kakhulu kule ndlela yokuzivikela ekubambiseni i-anaphylaxis enzima kakhulu.
Kwaphela iminyaka eminingi, allergists bakhathazeke ngokuthi kungenzeka ukungezwani kwemifino empeleni ukwenza dopatitis atopic nakakhulu. Lokhu kungenxa yokuthi i-dermatitis engapheliyo ihlukanisa izici ze-immunologic ngezifo ezizimele (ezifana ne- lupus ne-rheumatoid arthritis), okungase kube kubi nakakhulu ukudubula.
Nakuba ucwaningo oluningi lubonisa ukuthi i-immunotherapy iphephile futhi isebenza kahle nge-atopic dermatitis, abantu abangamaphesenti angama-20 babhekene nokuwohloka kwezibonakaliso zabo ze-atopic dermatitis ngezimpawu zokungabi namagciwane noma amaconsi.
Thola konke owake wafuna ukwazi nge- atermic dermatitis .
Imithombo:
I-Cox L, uNelson H, Lockey R. Allergen Immunotherapy: I-Parameter Update Update yesiThathu. J Allergy Clin Immunol. 2010;
I-Pajno GB, i-Caminiti L, i-Vita B, et al. I-Immunotherapy engezansi ezifundweni ze-Mite-Sensitized Izingane ezine-Atopic Dermatitis: Isifundo Esilawulwa Ngesivinini, Esi-Double-Blind, Esilawulwa Ngendawo. J Allergy Clin Immunol. 2007; 120: 164-70.
UBussmann C, Bockenhoff A, uHenke H, et al. Ingabe i-Allerggen-Specific Immunotherapy ibonisa indlela yokwelapha yeziguli ezine-Atopic Dermatitis? J Allergy Clin Immunol. 2006; 118: 1292-8.